United Arab Emirates

8 Vaccines Approved for Use in United Arab Emirates

Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Approval Source: scmp.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: tass.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: cnbc.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: u.ae
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: nature.com
Inactivated

Valneva

VLA2001

Approved in 33 countries
9 trials in 4 countries
Approval Source: valneva.com

9 in Clinical Trials in United Arab Emirates

Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Protein Subunit

Sinocelltech

SCTV01C

12 trials in 2 countries
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Protein Subunit

Jiangsu Rec-Biotechnology Co Ltd

ReCOV

6 trials in 3 countries
RNA

Suzhou Abogen Biosciences

ABO1009-DP

2 trials in 2 countries